ZA824726B - Medicament comprising the product of the reaction of a c1 to c6 carboxylic acid on a basic amino acid - Google Patents
Medicament comprising the product of the reaction of a c1 to c6 carboxylic acid on a basic amino acidInfo
- Publication number
- ZA824726B ZA824726B ZA824726A ZA824726A ZA824726B ZA 824726 B ZA824726 B ZA 824726B ZA 824726 A ZA824726 A ZA 824726A ZA 824726 A ZA824726 A ZA 824726A ZA 824726 B ZA824726 B ZA 824726B
- Authority
- ZA
- South Africa
- Prior art keywords
- acid
- reaction
- carboxylic acid
- basic amino
- medicament
- Prior art date
Links
- 150000001413 amino acids Chemical class 0.000 title abstract 3
- 150000001735 carboxylic acids Chemical class 0.000 title abstract 3
- 239000003814 drug Substances 0.000 title abstract 3
- FERIUCNNQQJTOY-UHFFFAOYSA-N Butyric acid Chemical compound CCCC(O)=O FERIUCNNQQJTOY-UHFFFAOYSA-N 0.000 abstract 4
- 239000004475 Arginine Substances 0.000 abstract 2
- WWZKQHOCKIZLMA-UHFFFAOYSA-N Caprylic acid Natural products CCCCCCCC(O)=O WWZKQHOCKIZLMA-UHFFFAOYSA-N 0.000 abstract 2
- 239000004472 Lysine Substances 0.000 abstract 2
- KDXKERNSBIXSRK-UHFFFAOYSA-N Lysine Natural products NCCCCC(N)C(O)=O KDXKERNSBIXSRK-UHFFFAOYSA-N 0.000 abstract 2
- 230000000259 anti-tumor effect Effects 0.000 abstract 2
- 230000000840 anti-viral effect Effects 0.000 abstract 2
- ODKSFYDXXFIFQN-UHFFFAOYSA-N arginine Natural products OC(=O)C(N)CCCNC(N)=N ODKSFYDXXFIFQN-UHFFFAOYSA-N 0.000 abstract 2
- GONOPSZTUGRENK-UHFFFAOYSA-N benzyl(trichloro)silane Chemical compound Cl[Si](Cl)(Cl)CC1=CC=CC=C1 GONOPSZTUGRENK-UHFFFAOYSA-N 0.000 abstract 2
- XBDQKXXYIPTUBI-UHFFFAOYSA-N dimethylselenoniopropionate Natural products CCC(O)=O XBDQKXXYIPTUBI-UHFFFAOYSA-N 0.000 abstract 2
- 229940079593 drug Drugs 0.000 abstract 2
- FUZZWVXGSFPDMH-UHFFFAOYSA-N n-hexanoic acid Natural products CCCCCC(O)=O FUZZWVXGSFPDMH-UHFFFAOYSA-N 0.000 abstract 2
- IUVKMZGDUIUOCP-BTNSXGMBSA-N quinbolone Chemical compound O([C@H]1CC[C@H]2[C@H]3[C@@H]([C@]4(C=CC(=O)C=C4CC3)C)CC[C@@]21C)C1=CCCC1 IUVKMZGDUIUOCP-BTNSXGMBSA-N 0.000 abstract 2
- 239000013543 active substance Substances 0.000 abstract 1
- 238000004519 manufacturing process Methods 0.000 abstract 1
- 238000000034 method Methods 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/415—1,2-Diazoles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/425—Thiazoles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/19—Cytokines; Lymphokines; Interferons
- A61K38/21—Interferons [IFN]
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Zoology (AREA)
- Gastroenterology & Hepatology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Immunology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Molecular Biology (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Abstract
1. Claims for the contracting States : BE, CH, DE, FR, GB, IT, LI, LU, NL, SE Antiviral and antitumoral drug, characterized by the fact that it contains as active substance at least one of the products of the reaction of a carboxylic acid of the groups comprising butyric, propionic and hexanoic acid with an amino-acid of the group consisting of arginine and lysine. 1. Claims for the contracting State : AT Process for the manufacture of an antiviral and antitumoral drug, characterized by the fact that at least one carboxylic acid of the groups comprising butyric, propionic and hexanoic acid is reacted with at least one basic amino-acid of the group consisting of arginine and lysine.
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| FR8113190A FR2508797B1 (en) | 1981-07-03 | 1981-07-03 | MEDICINAL PRODUCT COMPRISING THE REACTION OF A C1 TO C6 CARBOXYLIC ACID ON A BASIC AMINO ACID |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ZA824726B true ZA824726B (en) | 1983-04-27 |
Family
ID=9260209
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ZA824726A ZA824726B (en) | 1981-07-03 | 1982-07-02 | Medicament comprising the product of the reaction of a c1 to c6 carboxylic acid on a basic amino acid |
Country Status (7)
| Country | Link |
|---|---|
| EP (1) | EP0069659B1 (en) |
| JP (1) | JPS5813512A (en) |
| AT (1) | ATE19057T1 (en) |
| CA (1) | CA1209037A (en) |
| DE (1) | DE3270388D1 (en) |
| FR (1) | FR2508797B1 (en) |
| ZA (1) | ZA824726B (en) |
Families Citing this family (17)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| FR2587900B1 (en) * | 1985-10-01 | 1988-10-07 | Morelle Jean | BASIC FATTY-AMINO ACID ASSOCIATIONS WITH EMOLLIENT, EMULSIFIING AND ANTIOXIDANT PROPERTIES FOR COSMETICS, DERMATOLOGY AND FOOD |
| US4883661A (en) * | 1987-10-09 | 1989-11-28 | Daly John M | Use of arginine as an lymphokine synergist |
| HU209973B (en) * | 1988-03-09 | 1995-01-30 | Biorex Kutato Fejlesztoe Kft | Process for production of antiviral and immunstimular pharmaceutical composition |
| AT393080B (en) * | 1988-11-25 | 1991-08-12 | Lubec Gert | Pharmaceutical use of arginine (salts) |
| EP0596959B1 (en) * | 1991-07-26 | 2000-03-29 | Commonwealth Scientific And Industrial Research Organisation | Self-adjuvanting peptide vaccine delivery system and production thereof |
| US7910624B1 (en) | 1995-03-03 | 2011-03-22 | The Trustees Of Boston University | Compositions for the treatment of blood disorders |
| RO115498B1 (en) * | 1993-10-29 | 2000-03-30 | Univ Boston | Method for treating neoplasm |
| US6011000A (en) * | 1995-03-03 | 2000-01-04 | Perrine; Susan P. | Compositions for the treatment of blood disorders |
| CA2263675C (en) * | 1996-07-26 | 2010-04-13 | Douglas V. Faller | Compositions comprising an inducing agent and an anti-viral agent for the treatment of blood, viral and cellular disorders |
| US6197743B1 (en) | 1996-07-26 | 2001-03-06 | The Trustees Of Boston University | Compositions and methods for the treatment of viral disorders |
| DE19753321A1 (en) * | 1997-12-02 | 1999-06-10 | Basf Ag | Process for the production and use of lysine formate |
| CA2324426A1 (en) | 1998-02-11 | 1999-08-19 | Douglas V. Faller | Compositions and methods for the treatment of cystic fibrosis |
| WO2011038224A1 (en) | 2009-09-24 | 2011-03-31 | Trustees Of Boston University | Methods for treating viral disorders |
| EP2509418A4 (en) | 2009-12-08 | 2013-03-20 | Hemaquest Pharmaceuticals Inc | Methods and low dose regimens for treating red blood cell disorders |
| WO2011113013A2 (en) | 2010-03-11 | 2011-09-15 | Hemaquest Pharmaceuticals, Inc. | Methods and compositions for treating viral or virally-induced conditions |
| US20220226322A1 (en) | 2019-05-31 | 2022-07-21 | Viracta Subsidiary, Inc. | Methods of treating virally associated cancers with histone deacetylase inhibitors |
| CN113698893B (en) * | 2021-09-17 | 2022-07-08 | 吉林大学 | Hot melt adhesive formed by amino acid and fatty acid and preparation method thereof |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US2662046A (en) * | 1948-06-19 | 1953-12-08 | Merck & Co Inc | Parenteral amino acid solution |
| US3024272A (en) * | 1958-04-22 | 1962-03-06 | Du Pont | Organic acid salts of basic amino acids and their use |
| JPS5535049A (en) * | 1978-09-04 | 1980-03-11 | Otsuka Pharmaceut Factory Inc | Amino acid transfusion for cancerous patient |
-
1981
- 1981-07-03 FR FR8113190A patent/FR2508797B1/en not_active Expired
-
1982
- 1982-07-01 AT AT82401236T patent/ATE19057T1/en not_active IP Right Cessation
- 1982-07-01 DE DE8282401236T patent/DE3270388D1/en not_active Expired
- 1982-07-01 EP EP82401236A patent/EP0069659B1/en not_active Expired
- 1982-07-02 JP JP57115306A patent/JPS5813512A/en active Pending
- 1982-07-02 CA CA000406505A patent/CA1209037A/en not_active Expired
- 1982-07-02 ZA ZA824726A patent/ZA824726B/en unknown
Also Published As
| Publication number | Publication date |
|---|---|
| FR2508797B1 (en) | 1986-03-14 |
| FR2508797A1 (en) | 1983-01-07 |
| EP0069659B1 (en) | 1986-04-09 |
| CA1209037A (en) | 1986-08-05 |
| EP0069659A1 (en) | 1983-01-12 |
| ATE19057T1 (en) | 1986-04-15 |
| JPS5813512A (en) | 1983-01-26 |
| DE3270388D1 (en) | 1986-05-15 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ZA824726B (en) | Medicament comprising the product of the reaction of a c1 to c6 carboxylic acid on a basic amino acid | |
| AU642913B2 (en) | New esters of thienyl carboxylic acids and amino alcohols, their quaternization products, and the manufacture and use of said compounds | |
| FR2395296A1 (en) | USE OF CARBOXYLIC ACID ESTERS AND TERTIARY ALKYLOLAMINES FOR THE TREATMENT OF PIGMENTS IN INORGANIC LOADING MATERIALS WHOSE DISPERSABILITY IS INTENDED TO IMPROVE | |
| AU5828580A (en) | Preparation of n-phosphonomethyl glycine | |
| GB8607137D0 (en) | Compositions | |
| GR3004253T3 (en) | ||
| CA2015291A1 (en) | Macromolecular endoplasmic reticulum | |
| ES2055407T3 (en) | ANALOGS OF OXY- OR THIO-SUBSTITUTED FATTY ACIDS TO BE USED IN THE TREATMENT OF RETROVIRAL INFECTIONS. | |
| DE3371627D1 (en) | Acetylsalicylic acid thioesters, a process for their preparation and pharmaceutical compositions containing them | |
| FI854025A0 (en) | FORMULATION OF FRAMSTANT SUBSTANCES WITH L-AMINOSYROR. | |
| DE59002845D1 (en) | Process for the production of spherical particles of magnesium alkoxide. | |
| AU581185B2 (en) | Process for the racemization of optically active aminoacids | |
| JPS5218886A (en) | Production of amino acids by fermentation process | |
| OA05233A (en) | Process for the preparation of (7-acetamido Disubstitue) -3- substitute-3- cephem-4-carboxylic acids and new industrial products. | |
| DE2960574D1 (en) | Process for the preparation of oxazolidine-2,4 diones | |
| SE7904139L (en) | PROCEDURE FOR THE PREPARATION OF 1,5-DIMETHYL-BICYCLO (3.2.1) OCTANOL-8 | |
| GB2129806B (en) | Process for preparing high-dextrose starch hydrolysates with immobilized glucoamylase | |
| DE3061270D1 (en) | Process for preparing methylene-bis-phenylcarbamic acid esters and polymethylene polyphenylcarbamic acid esters | |
| FR2708929B1 (en) | Process for the preparation of cyclopropane-1,1-dicarboxylic acid esters. | |
| PT70367A (en) | Process for the preparation of 4,4-dimethyl-4-sila-fatty acid amides with pharmaceutical effect | |
| DE2961892D1 (en) | N-benzoyl-retinyl amines, process for their preparation, pharmaceutical compositions comprising them and the use of these compounds for the therapy and prophylaxis of precanceroses and carcinomas of the skin | |
| JPS527915A (en) | Process for preparation of higher fatty acid | |
| JPS52106817A (en) | Preparation of cyanomethylthioacetic acids | |
| JPS57131792A (en) | Novel 2-oxabicyclo(2.2.2)octan-3-one derivative | |
| EP0345457A3 (en) | Antinflammatory agent for the therapy of prostatic hypertrophy, a process for the preparation thereof and pharmaceutical compositions containing it |